1. Home
  2. SXTC vs BGB Comparison

SXTC vs BGB Comparison

Compare SXTC & BGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXTC
  • BGB
  • Stock Information
  • Founded
  • SXTC 2005
  • BGB 2012
  • Country
  • SXTC China
  • BGB United States
  • Employees
  • SXTC N/A
  • BGB N/A
  • Industry
  • SXTC Biotechnology: Pharmaceutical Preparations
  • BGB Trusts Except Educational Religious and Charitable
  • Sector
  • SXTC Health Care
  • BGB Finance
  • Exchange
  • SXTC Nasdaq
  • BGB Nasdaq
  • Market Cap
  • SXTC 1.6M
  • BGB N/A
  • IPO Year
  • SXTC 2019
  • BGB N/A
  • Fundamental
  • Price
  • SXTC $0.42
  • BGB $12.26
  • Analyst Decision
  • SXTC
  • BGB
  • Analyst Count
  • SXTC 0
  • BGB 0
  • Target Price
  • SXTC N/A
  • BGB N/A
  • AVG Volume (30 Days)
  • SXTC 2.3M
  • BGB 154.6K
  • Earning Date
  • SXTC 01-01-0001
  • BGB 01-01-0001
  • Dividend Yield
  • SXTC N/A
  • BGB 9.75%
  • EPS Growth
  • SXTC N/A
  • BGB N/A
  • EPS
  • SXTC N/A
  • BGB N/A
  • Revenue
  • SXTC $1,928,497.00
  • BGB N/A
  • Revenue This Year
  • SXTC N/A
  • BGB N/A
  • Revenue Next Year
  • SXTC N/A
  • BGB N/A
  • P/E Ratio
  • SXTC N/A
  • BGB N/A
  • Revenue Growth
  • SXTC N/A
  • BGB N/A
  • 52 Week Low
  • SXTC $0.30
  • BGB $10.40
  • 52 Week High
  • SXTC $6.39
  • BGB $11.97
  • Technical
  • Relative Strength Index (RSI)
  • SXTC 49.40
  • BGB 39.98
  • Support Level
  • SXTC $0.37
  • BGB $12.18
  • Resistance Level
  • SXTC $0.49
  • BGB $12.44
  • Average True Range (ATR)
  • SXTC 0.05
  • BGB 0.13
  • MACD
  • SXTC 0.01
  • BGB -0.03
  • Stochastic Oscillator
  • SXTC 52.19
  • BGB 11.92

About SXTC China SXT Pharmaceuticals Inc.

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Share on Social Networks: